These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1720 related articles for article (PubMed ID: 16492545)

  • 1. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gastric emptying.
    Young A
    Adv Pharmacol; 2005; 52():99-121. PubMed ID: 16492543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of food intake.
    Young A
    Adv Pharmacol; 2005; 52():79-98. PubMed ID: 16492542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.
    Castillo MJ; Scheen AJ; Lefèbvre PJ
    Diabete Metab; 1995 Feb; 21(1):3-25. PubMed ID: 7781840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amylin and the integrated control of nutrient influx.
    Young A
    Adv Pharmacol; 2005; 52():67-77. PubMed ID: 16492541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly approved and promising antidiabetic agents.
    Combettes M; Kargar C
    Therapie; 2007; 62(4):293-310. PubMed ID: 17983555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
    Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
    J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus.
    Fineman M; Weyer C; Maggs DG; Strobel S; Kolterman OG
    Horm Metab Res; 2002 Sep; 34(9):504-8. PubMed ID: 12384827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects in skeletal muscle.
    Young A
    Adv Pharmacol; 2005; 52():209-28. PubMed ID: 16492548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses.
    Rijkelijkhuizen JM; McQuarrie K; Girman CJ; Stein PP; Mari A; Holst JJ; Nijpels G; Dekker JM
    Metabolism; 2010 Apr; 59(4):502-11. PubMed ID: 19846181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of amylin in the physiology of glycemic control.
    Scherbaum WA
    Exp Clin Endocrinol Diabetes; 1998; 106(2):97-102. PubMed ID: 9628238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of amylin (islet amyloid polypeptide) on insulin response to non-glucose stimuli. Study in perfused rat pancreas.
    Salas M; Silvestre RA; Garcia-Hermida O; Fontela T; Rodriguez-Gallardo J; Marco J
    Diabete Metab; 1995 Oct; 21(4):269-73. PubMed ID: 8529762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.
    Koopmans SJ; Radder JK; Krans HM; Barge RM
    Neth J Med; 1992 Aug; 41(1-2):82-90. PubMed ID: 1407245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
    Baron AD; Kim D; Weyer C
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic alpha-cell dysfunction in diabetes.
    Burcelin R; Knauf C; Cani PD
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S49-55. PubMed ID: 18640586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin as a physiological modulator of glucagon secretion.
    Bansal P; Wang Q
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E751-61. PubMed ID: 18647881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.